Incidence rates for renal cell cancer have been rising by nearly 2% per year in the USA since the 1970s (Mathew et al., 2002; Jemal et al., 2008) . Perhaps the most salient feature of these incidence trends has been the more rapid increase among blacks than whites, leading to a pronounced shift in excess from among whites to among blacks beginning as far back as the mid 1980s ( Fig. 1 ) (Kosary and McLaughlin, 1993) . By 2002-2007, the age-adjusted incidence rates of renal cell cancer among black men, white men, black women, and white women were 20.0, 17.4, 9.6, and 8.8 per 100 000 person-years, respectively (National Cancer Institute, 2009 ).
In contrast to the incidence trends, there has been a convergence over the past four decades of US national kidney cancer mortality rates, with rates becoming more or less identical among blacks and whites for both men and women since the early 1990s (Fig. 2) . Such similarity in mortality rates is unexpected and has not been observed, to our knowledge, for any other type of cancer that exhibits a strong black excess in incidence. Although mortality data do not permit the separation of renal cell from other forms of kidney cancer, renal cell cancers account for approximately 85% of kidney cancers, and little difference in survival by cell type has been reported (Lipworth et al., 2006) , such that the kidney cancer mortality trends primarily reflect patterns related to renal cell cancer.
The higher incidence of renal cell cancer among blacks is almost entirely accounted for by an excess of localized disease. During 2000-2007, the incidence rate of localized renal cell cancer was 13.2 per 100 000 personyears among black men, compared with 10.8 among white men (Table 1) ; corresponding figures among black and white women were 6.9 and 6.0, respectively. When examined by age and sex, the excess of localized renal cell cancer among blacks is evident among both younger and older patients and is more pronounced among men than women. For regional and distant renal cell cancer, incidence rates were similar between blacks and whites, with, if anything, slight deficits among black men and women, particularly in those above the age of 60 years.
The higher incidence of localized disease among blacks occurred as early as the 1970s; for the periods 1973-1977, 1978-1982, and 1983-1987 , the incidence rates (per 100 000) for localized renal cell cancer were 3.7, 4.7, and 6.1 for black men, 3.5, 3.9, and 5.0 for white men, 1.8, 2.2, and 2.8 for black women, and 1.7, 1.8, and 2.3 for white women, respectively. Localized renal cell cancer has also been increasing at a significantly faster pace among blacks of all ages than among whites since the 1970s (Vaishampayan et al., 2003) . These incidence patterns are puzzling and unexpected, particularly since early stage, localized renal cell cancer is generally asymptomatic and primarily detected incidentally by imaging modalities such as computed tomography or ultrasonography, which have been shown to be used less frequently by blacks than whites (Geronimus et al., 1996; Vaishampayan et al., 2003) .
For early-stage, localized renal cell cancer, cause-specific survival rates (which represent the probability of a kidney cancer case dying with kidney cancer as the cause of death) are high (> 90%) and virtually identical among blacks and whites (Table 1) , regardless of age or sex, such that most kidney cancer deaths occur among patients with regional or distant disease. For regional or distant disease, causespecific survival is also generally comparable between blacks and whites (Table 1) . To determine whether higher stagespecific rates of nephrectomies, the only effective treatment for renal cell cancer, among blacks may help explain the equivalent mortality rates among blacks and whites, we examined surgery codes for kidney cancer in the Surveillance Epidemiology and End Results 17 Registries from 2000 to 2007. As shown in Table 1 , rates of nephrectomy are in fact slightly lower among blacks than among whites with localized renal cell cancer, despite the virtually identical cause-specific survival. For distant disease, which accounts for a small fraction of the renal cell cancer incidence excess in younger blacks, the disparity in nephrectomy rates by race is even larger, with blacks undergoing such surgery much less frequently, whereas cause-specific survival for distant disease is paradoxically higher among blacks, particularly among those above the age of 60 years. For unstaged renal cell cancer, blacks have substantially lower nephrectomy rates, but comparable or higher survival rates, compared with whites. Zini et al. (2008) have also reported similar survival despite lower nephrectomy rates among blacks, although others have reported lower survival rates among blacks compared with whites with renal cell cancer (Berndt et al., 2007; Stafford et al., 2008) .
A close examination of incidence and mortality trends for renal cancer by race over the past 40 years shows a pattern of higher and more rapidly increasing incidence among blacks compared with whites, which is not reflected in the virtually identical mortality rates of whites and blacks over the same time period. This equivalence in mortality despite higher incidence does not seem to be a result of higher rates of nephrectomies among blacks; nor is there any obvious explanation for the almost 30% higher incidence of localized disease among blacks. The possibility that the biology or natural history of renal cell cancer may differ among blacks and whites, particularly in its aggressiveness, is suggested by the favorable stage distribution among blacks and their higher survival for distant and unstaged cancer. Moreover, rates of end stage renal disease, in particular hypertensionrelated end-stage renal disease, are at least four-fold higher among blacks than among whites, and 20 times higher among young black males (US Renal Data System, USRDS 2009 Annual Data Report, 2010 . Among blacks, focal segmental glomerulosclerosis and hypertension-attributed end-stage kidney disease are strongly associated with variants in the APOL1 gene on chromosome 22 (Genovese et al., 2010) . The variants are common in African-Americans and appear to be absent in European-Americans, supporting a White male Black male White female Black female 5 10 1 1 9 7 1 − 1 9 7 3 1 9 7 4 − 1 9 7 6 1 9 7 7 − 1 9 7 9 1 9 8 0 − 1 9 8 2 1 9 8 6 − 1 9 8 8 1 9 8 9 − 1 9 9 1 1 9 9 5 − 1 9 9 7 1 9 9 8 − 2 0 0 0 2 0 0 1 − 2 0 0 3 2 0 0 4 − 2 0 0 6 Rate per 100 000 person (years) 1 9 8 3 − 1 9 8 5
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Year of diagnosis 1 9 9 2 − 1 9 9 4 genetic basis for racial heterogeneity in susceptibility to, and possibly other aspects of, kidney disease (Genovese et al., 2010) .
Further research into the enigmatic descriptive epidemiology and natural history of renal cell cancer may point to clues in the etiology of this malignancy and its more common occurrence among black Americans, which has persisted for several decades. 
